“In conclusion, these findings provide evidence that I3C enhances sorafenib anti-cancer activity in HCC cells.”
“The results show that the ability of I3C to enhance sorafenib cytotoxicity in HCC cells could be partially attributed to increasing the apoptotic activity and decreasing the angiogenic potentials.”